VerifiedEvidence: highv1.0.0

Benefit-Cost Ratio

The ratio of the monetised value of a programme's benefits to its costs, used as a summary measure in cost-benefit analysis.

Last reviewedDarrin Baines IP Ltd

Concept Architecture

Concept

Theoretically, the Benefit-Cost Ratio (BCR) is a summary measure used in cost-benefit analysis to compare the monetary value of benefits generated by a healthcare intervention with the monetary value of the resources required to implement it. It is based on welfare economics and the principle that interventions should be undertaken when the value of their benefits exceeds their costs. The ratio provides a measure of the economic return generated for each unit of expenditure.

Mathematically, the Benefit-Cost Ratio is represented as the ratio of the present value of total benefits to the present value of total costs. It estimates the economic efficiency of an intervention, with values greater than one indicating that benefits exceed costs.

In practice, the Benefit-Cost Ratio is calculated by discounting future costs and benefits to their present values before dividing total discounted benefits by total discounted costs. It is widely used in cost-benefit analyses of public health programmes, healthcare investments and policy evaluations where both costs and outcomes are expressed in monetary terms.


Purpose

Used to assess whether the economic benefits of a healthcare intervention exceed its costs, compare alternative investments, support resource allocation decisions, and evaluate value for money within cost-benefit analysis.


Mathematical Formulae

Primary Formula

BCR = (????? B? / (1 + r)?) / (????? C? / (1 + r)?)

Where:

  • B? = Benefits in period t
  • C? = Costs in period t
  • r = Discount rate
  • T = Time horizon

Supporting Formulae

Present Value of Benefits:

PV(B) = ????? B? / (1 + r)?

Present Value of Costs:

PV(C) = ????? C? / (1 + r)?

Related Mathematical Methods

  • Cost-Benefit Analysis (CBA)
  • Net Present Value (NPV)
  • Discounting
  • Internal Rate of Return (IRR)

Example

A vaccination programme has discounted benefits of �18,000,000 and discounted costs of �6,000,000.

BCR = 18,000,000 / 6,000,000 = 3.0

The programme generates �3 of economic benefit for every �1 invested, indicating that the intervention is economically worthwhile.


Excel Implementation

FunctionExample FormulaHealth Economics Application
NPV=NPV(B1,C2:C11)Calculate the present value of benefits or costs.
Division=B12/C12Calculate the Benefit-Cost Ratio.
SUM=SUM(C2:C11)Calculate undiscounted total benefits or costs where appropriate.
IF=IF(B12/C12>1,"Accept","Reject")Determine whether benefits exceed costs.

VBA (Optional)

Automate the calculation of discounted benefits, discounted costs and Benefit-Cost Ratios for multiple healthcare investment scenarios.


Sources

  • Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford University Press.
  • Boardman AE, Greenberg DH, Vining AR, Weimer DL. Cost-Benefit Analysis: Concepts and Practice.
  • Briggs A, Claxton K, Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford University Press.
  • NICE. Health Technology Evaluation Manual.

Library

Publications

4
  • Guidance

    NICE DSU Technical Support Document 11: Alternatives to EQ-5D for Generating Health State Utility Values — Brazier, Rowen, TSD 11 ed., 2011 (NICE Decision Support Unit (University of Sheffield))

    Guidance on alternatives to EQ-5D — including SF-6D, HUI, condition-specific preference-based measures, direct valuation and vignette methods — for generating health-state utility values.

  • BookFeatured

    Cost-Benefit Analysis: Concepts and Practice — Anthony E. Boardman, David H. Greenberg, Aidan R. Vining and David L. Weimer, 5th Edition ed., 2018 (Cambridge University Press)

    An authoritative treatment of welfare-economic foundations, valuation methods, discounting, uncertainty and practical protocols for social cost-benefit analysis.

  • GuidanceFeatured

    The Green Book 2026 — HM Treasury, 2026 (UK Government)

    UK government guidance for appraising the social costs, benefits and risks of alternative policies, programmes and projects.

  • GuidanceFeatured

    OMB Circular A-4: Regulatory Analysis — Office of Management and Budget, Reinstated 2025 ed., 2003 (Executive Office of the President of the United States)

    Federal guidance on benefit-cost analysis, baseline selection, valuation, discounting, uncertainty and comparison of regulatory alternatives.

Tools & Resources

1
  • Guidance

    OMB Circular A-94: Guidelines and Discount Rates for Benefit-Cost Analysis of Federal Programs — Office of Management and Budget, Current official copy ed., 1992 (Executive Office of the President of the United States)

    Guidance on conducting benefit-cost analysis and applying discount rates to US federal programmes and investments.

Frequently Asked Questions (6)

  • What is a benefit-cost ratio?

    The ratio of the monetised value of a programme's benefits to its costs, used as a summary measure in cost-benefit analysis.

    Source: Boardman et al. 2011

  • How is benefit-cost ratio calculated?

    Benefits and costs occurring in different years are each discounted to present value, and the present value of benefits is divided by the present value of costs. Both sides must be expressed in money, which for a health programme means placing a monetary value on health outcomes as well as on resource savings. The discount rate applied is a decision made before the calculation and materially affects the result wherever benefits arrive later than costs, which is usual.

    Source: Boardman et al. 2011

  • Why is a benefit-cost ratio sensitive to how items are classified?

    Because a negative benefit and a positive cost are arithmetically equivalent but land on different sides of the division. Treating an ongoing operating cost as a deduction from benefits rather than as an addition to costs changes the ratio without changing the underlying project at all, and the same choice leaves net present value untouched. Ratios from different studies are therefore not comparable unless the classification conventions match, and this is the defect most often cited against the measure.

    Source: Boardman et al. 2011

  • When should net present value be used instead of a benefit-cost ratio?

    For deciding whether a single project is worthwhile, and for choosing between mutually exclusive options, net present value is the correct criterion because it measures the size of the gain rather than its proportion. A small project with a high ratio can produce far less total benefit than a large one with a lower ratio, and choosing on the ratio forgoes the difference. The ratio becomes useful where a fixed budget must be allocated across independent projects, since ranking by benefit per unit of outlay then approximates the best use of the constraint.

    Source: Mishan & Quah 2007

  • How does a benefit-cost ratio give health benefits a monetary value?

    Three approaches are used. Stated preference methods ask people directly what they would pay for a stated reduction in risk or improvement in health. Revealed preference methods infer the value from choices actually made in labour and consumer markets, most commonly from wage differences associated with occupational risk. Human capital approaches value health through earnings forgone. The values obtained differ substantially between methods, and the choice of method can matter more to the conclusion than any other input.

    Source: Viscusi & Aldy 2003

  • Why is the benefit-cost ratio used less in health than in other sectors?

    The central objection is that valuations derived from what people can pay embed their ability to pay, so the same health improvement is valued more highly in a richer person, which conflicts with the principle that a unit of health counts equally regardless of who receives it. Many find the exercise of pricing life and health objectionable in itself. Cost-effectiveness analysis avoids both difficulties by leaving health in natural or preference-based units and declining to convert it, at the cost of being unable to compare health against spending in other sectors.

    Source: Drummond et al. 2015

Trust Record

Verified by Dr Darrin Baines

British health economist

Professional identity: darrinbaines.org

Verification date: 31 Jul 2025

Content version: 1.0.0

Canonical Identity

Term code
HE-EE-CBA-004

Stable URI · Machine-readable · Resolvable · CC BY 4.0